0 0 Vivalex UK Limited 06293776 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is that of a commission agents in the field of general consultancy and advisory services including marketing analysis and reporting, technical consultancy, introduction of clients, intermediation services, marketing and corporate management solutions in the renewable energy sector. Digita Accounts Production Advanced 6.30.9574.0 true 06293776 2024-07-01 2025-06-30 06293776 2025-06-30 06293776 bus:OrdinaryShareClass1 2025-06-30 06293776 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2025-06-30 06293776 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 06293776 bus:SmallEntities 2024-07-01 2025-06-30 06293776 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 06293776 bus:FilletedAccounts 2024-07-01 2025-06-30 06293776 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 06293776 bus:RegisteredOffice 2024-07-01 2025-06-30 06293776 bus:Director2 2024-07-01 2025-06-30 06293776 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 06293776 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 06293776 countries:EnglandWales 2024-07-01 2025-06-30 06293776 2023-07-01 2024-06-30 06293776 2024-06-30 06293776 bus:OrdinaryShareClass1 2024-06-30 06293776 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 06293776 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 06293776

Vivalex UK Limited
Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 June 2025

Vivalex UK Limited

Contents

Abridged Balance Sheet | 1
Notes to the Unaudited Abridged Financial Statements | 2 to 4

Vivalex UK Limited

(Registration number: 06293776)
Abridged Balance Sheet as at 30 June 2025

| Note | 2025 € | 2024 €
Fixed assets |  |  |
Other financial assets | 4 | 38,023 | 37,841
Current assets |  |  |
Cash at bank and in hand |  | 814,938 | 1,268,948
Prepayments and accrued income |  | 1,066 | 1,061
Creditors: Amounts falling due within one year |  | (31,660) | (31,660)
Net current assets |  | 784,344 | 1,238,349
Total assets less current liabilities |  | 822,367 | 1,276,190
Accruals and deferred income |  | (2,985) | (2,970)
Net assets |  | 819,382 | 1,273,220
Capital and reserves |  |  |
Called up share capital | 5 | 1 | 1
Retained earnings |  | 819,381 | 1,273,219
Shareholders' funds |  | 819,382 | 1,273,220

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 9 March 2026

......................................... Mr R A Popoiu Director

Vivalex UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
5th Floor, North Side
7/10 Chandos Street
London
W1G 9DQ

These financial statements were authorised for issue by the director on 9 March 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Vivalex UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

Vivalex UK Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

4 | Other financial assets (current and non-current)

| Financial assets at cost less impairment € | Total €
Non-current financial assets
Cost or valuation
At 1 July 2024 | 37,841 | 37,841
Additions | 182 | 182
At 30 June 2025 | 38,023 | 38,023
Impairment
Carrying amount
At 30 June 2025 | 38,023 | 38,023

5 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | € | No. | €
Ordinary shares of €1 each | 1 | 1 | 1 | 1

6 | Dividends

Final dividends paid

|  | 2025 € |  | 2024 €
Final dividend of €1,250,000.00 (2024 - €Nil) per each Ordinary shares |  | 1,250,000 |  | -